Hep Talk

Cost of treatment and prevention in the war on viral hepatitis was the overriding theme of the first World Hepatitis Summit, which drew more...

Talking About It A documentary put human faces on hep B in Asian-American communities by Larry Buhl According to the U.S. Centers for Disease Control and Prevention...

Doing No Harm Amid our injection drug epidemic, service providers rethink strategies for reducing unsafe practices by Larry Buhl The U.S. is in the midst of an...

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

Last fall the New York State Department of Corrections and Community Supervision (DOCCS) ended its policy of excluding prisoners from any hepatitis C treatment...

As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s...

Entry inhibitors usher in a new phase of hep C research by Larry Buhl Future therapy for hepatitis C infection may include a variety of drugs...

HCV advocate, author & nurse Lucinda Porter offers perspectives on care by Larry Buhl Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and...

Full Treatment A former inmate pushed for Nevada Corrections to treat everyone with HCV by Larry Buhl With a federal class-action lawsuit filed in October, Nevada has...